Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.48 |
| ▸ | GAA | P10253 | 4/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.43 |
| ▸ | MGAM | O43451 | 2/20 | 0.43 |
| ▸ | SI | P14410 | 2/20 | 0.43 |
| ▸ | MGAM2 | Q2M2H8 | 2/20 | 0.43 |
| ▸ | HTT | P42858 | 3/20 | 0.36 |
| ▸ | RECQL | P46063 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | TET2 | Q6N021 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.34 |
| ▸ | CA12 | O43570 | 1/20 | 0.34 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 4/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27984925 | 0.97 | TSHR (0.46) | TSHRGAAHSD17B10MGAMSI | |
| SCHEMBL13211935 | 0.84 | TSHR (0.39) | TSHRGAAHSD17B10MGAMSI | |
| SCHEMBL28378728 | 0.83 | ALDH1A1 (0.38) | TSHRGAAHSD17B10MGAMSI | |
| SCHEMBL10211016 | 0.82 | GAA (0.44) | TSHRGAAHSD17B10MGAMSI | |
| SCHEMBL13644543 | 0.82 | TSHR (0.37) | TSHRGAAHSD17B10MGAMSI | |
| SCHEMBL8488294 | 0.81 | TSHR (0.33) | TSHRGAAHSD17B10MGAMSI | |
| SCHEMBL13502967 | 0.81 | TSHR (0.33) | TSHRGAAHSD17B10MGAMSI | |
| SCHEMBL10211471 | 0.79 | NPC1 (0.44) | TSHRGAAHSD17B10MGAMSI | |
| SCHEMBL27230 | 0.78 | TSHR (0.48) | TSHRGAAHSD17B10MGAMSI | |
| SCHEMBL1881180 | 0.77 | LMNA (0.42) | TSHRGAAHTTRECQLLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 982 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3897833-B1 | INHIBITORS OF APOL1 AND METHODS OF USING SAME | VERTEX PHARMA (US) | 2026-02-04 | — | — | EP | claimed |
| WO-2025111296-A1 | ELECTROLYTE COMPOSITIONS AND ELECTROCHEMICAL DEVICES USING THE SAME | II-VI DELAWARE, INC. (US) | 2025-05-30 | — | — | WO | claimed |
| CN-118978438-A | Method for co-producing 3, 3-dimethoxy methyl propionate and 3-methoxy methyl acrylate | 上海燮宸新材料科技有限公司 | 2024-11-19 | — | — | CN | claimed |
| CN-113896637-B | Preparation method of 3, 3-dimethoxy methyl propionate | 昂吉(上海)环保新材料科技有限公司 | 2024-06-07 | — | — | CN | claimed |
| CN-113896634-B | Preparation method of 3-methoxy methyl acrylate | 昂吉(上海)环保新材料科技有限公司 | 2024-05-31 | — | — | CN | claimed |
| CN-113453760-B | APOL1 inhibitors and methods of use thereof | 弗特克斯药品有限公司 | 2024-05-24 | — | — | CN | claimed |
| WO-2023195412-A1 | LIGHT EMITTING ELEMENT, DISPLAY DEVICE, METHOD FOR PRODUCING NANOPARTICLE DISPERSION LIQUID, AND NANOPARTICLE DISPERSION LIQUID | シャープディスプレイテクノロジー株式会社 | 2023-10-12 | — | — | WO | claimed |
| US-20230279010-A1 | PROCESSES FOR PREPARING MODULATORS OF ALPHA-1 ANTITRYPSIN | VERTEX PHARMACEUTICALS INCORPORATED | 2023-09-07 | — | — | US | claimed |
| EP-4188931-A2 | PROCESSES FOR PREPARING MODULATORS OF ALPHA-1 ANTITRYPSIN | Vertex Pharmaceuticals Incorporated (US) | 2023-06-07 | — | — | EP | claimed |
| CN-116234809-A | Methods of preparing alpha-1 antitrypsin modulators | 弗特克斯药品有限公司 | 2023-06-06 | — | — | CN | claimed |
| CN-104230990-B | 2-((4R, 6S)-6-triphenylphosphine alkene methene base-2,2-is disubstituted-1,3-dioxane-4-yl) acetic acid esters and preparation method thereof and application | XINFA PHARMACEUTICAL CO., LTD. (CN) | 2016-05-11 | — | — | CN | claimed |
| CN-104230880-B | The simple and convenient process for preparing of 2-((4R, 6R)-6-aminoethyl-2,2-dimethyl-1,3-dioxane-4-yl) acetic acid esters | XINFA PHARMACEUTICAL CO., LTD. (CN) | 2016-05-04 | — | — | CN | claimed |
| CN-104230990-A | 2-((4R,6S)-6-triphenylphosphoalkenylmethylene-2,2-disubstituted-1,3-dioxyhexacyclo-4-yl)acetate, and preparation method and application thereof | XINFA PHARMACEUTICAL CO LTD | 2014-12-24 | — | — | CN | claimed |
| CN-104230880-A | Simple preparation method of 2-((4R,6R)-6-aminoethyl-2,2-dimethyl-1,3-dioxyhexacyclo-4-yl)acetate | XINFA PHARMACEUTICAL CO LTD | 2014-12-24 | — | — | CN | claimed |
| CN-102924391-A | 3,3-dimethoxy-2[2-(2-substituted-4-chlorotriazine oxygen) phenyl] methyl propionate bactericide and synthesis method for same | UNIV SICHUAN | 2013-02-13 | — | — | CN | claimed |
| EP-1907503-A1 | CORROSION INHIBITOR OR INTENSIFIER FOR USE IN ACIDIZING TREATMENT FLUIDS | Halliburton Energy Services, Inc. (US) | 2008-04-09 | — | — | EP | claimed |
| WO-2007007025-A1 | CORROSION INHIBITOR OR INTENSIFIER FOR USE IN ACIDIZING TREATMENT FLUIDS | HALLIBURTON ENERGY SERVICES, INC. (US) | 2007-01-18 | — | — | WO | claimed |
| US-20070010404-A1 | Corrosion inhibitor or intensifier for use in acidizing treatment fluids | HALLIBURTON ENERGY SERVICES, INC. | 2007-01-11 | — | — | US | claimed |
| EP-0257557-B1 | PROCESS FOR THE PREPARATION OF BIFUNCTIONAL COMPOUNDS | BASF Aktiengesellschaft (DE) | 1991-12-04 | — | — | EP | claimed |
| US-4812593-A | ZEOLITE CONVERSION OF A TETRALKOXYALKANE OR A DIALKOXYALKANOATE | BASF AKTIENGESELLSCHAFT (DE) | 1989-03-14 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230279010-A1 | PROCESSES FOR PREPARING MODULATORS OF ALPHA-1 ANTITRYPSIN | SERPINA2, SERPINC1, SERPINE1 | TSHR 588/4885GAA 144/4885HSD17B10 3079/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.